ArticleProceedings of the National Academy of Sciences of the United States of America2020
Correction for Srinivasan et al., MiR223-3p promotes synthetic lethality in BRCA1-deficient cancers.
PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.